Related Experiment Video
Updated: Dec 12, 2025

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
Published on: June 15, 2021
From Human Pluripotent Stem Cells to 3D Cardiac Microtissues: Progress, Applications and Challenges
Mariana A Branco1, Joaquim M S Cabral1, Maria Margarida Diogo1
1iBB-Institute for Bioengineering and Biosciences and Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisbon, Portugal.
Generating cardiac cells from human pluripotent stem cells (hPSCs) is advancing. Transitioning to 3D cardiac microtissues (MTs) enhances disease modeling and drug testing applications.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Tissue Engineering
Background:
- Human pluripotent stem cells (hPSCs) are vital for generating cardiomyocytes (CMs) and other cardiac cells.
- Advancements in directed differentiation protocols have improved cardiac cell generation from hPSCs.
- Cardiac cell differentiation has progressed from 2D cultures to complex 3D multicellular cardiac microtissues (MTs).
Purpose of the Study:
- To review the current state of cardiac cell generation from hPSCs.
- To evaluate the impact of transitioning CM differentiation from 2D to 3D environments.
- To highlight methods for generating 3D cardiac MTs and their applications.
Main Methods:
- Review of existing literature on hPSC-derived cardiac cells.
- Analysis of 2D to 3D culture transition in CM differentiation.
- Examination of methods for 3D cardiac MT formation.
- Assessment of in vitro applications and high-throughput screening adaptations.
Main Results:
- Directed differentiation protocols effectively generate various cardiac cells from hPSCs.
- 3D cardiac microtissues offer enhanced potential for studying cardiac disorders in vitro.
- 3D models are increasingly adopted for drug screening and cardiotoxicity testing.
Conclusions:
- The transition to 3D cardiac microtissues represents a significant advancement in cardiac cell modeling.
- These multicellular models improve the study of cardiac diseases and facilitate drug development.
- Adaptation to high-throughput screening settings broadens the clinical relevance of hPSC-derived cardiac models.
More Related Videos
10:37Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Published on: March 14, 2021
09:23Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
Published on: March 10, 2023